Search results for: 'post development'

In the post-pandemic scenario, city governments invest in the effective use of data to deliver efficient urban transport systems, a cleaner environment, robust urban infrastructure, and improve city dwellers' overall quality of life. Frost & Sullivan's IoT Building Smart Cities: Growth Opportunities for IoT Start-ups is a resource to help the ecosy...

After experiencing a significant post-Covid slump, the webinars and virtual events market returned to moderate growth in 2024. Growing at 4.8 percent over the previous year, revenue in 2024 is estimated to reach $1.45 billion. As in-person event attendance surged to its highest level in more than four years, event vendors have realigned their sol...

South America has experienced significant growth in the last 10 years, but it was focused only on specific countries. Driven by the Brazilian market, the continent has experience an influx of new destinations, especially from the North American market. The low average income GDP per capita is a significant deterrent, and the complicated political ...

Industry-wide fleet average CO2 emission targets for 2025 have been set to be 15% lower than 2020 levels, while 2030 levels will be 37.5% lower than 2020 levels. These targets are more stringent and are for cars only (separate targets are set for LCVs). Once the focus area for emission reduction, developments in IC engines no longer play an inte...

The pharmaceutical (pharma) industry is undergoing significant regulatory changes resulting from the European Green Deal and the Paris Agreement. These changes require pharma companies to adopt more environmentally sustainable practices. With the increasing demand for drugs globally, pharma R&D and manufacturing infrastructure has grown, leading to...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

05 Feb 2021  |  North America  |  Market Research

Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

Infographics

×

The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

19 Apr 2017  |  Asia Pacific  |  Market Research

Global CRO Market, Forecast to 2021

The Global CRO Market to Reach $64.58 Billion by 2021

Infographics

×

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

People are moving away from car ownership to usership models. As cost of ownership and cities' push for sustainable modes increase, the uptake of alternative mobility modes will also rise. Cities are framing regulations to promote the use of shared mobility modes. With car ownership set to decrease, OEMs are looking at expanding the relevance o...